About Pete Sommerness

I have the pleasure to lead the seasoned team at Respicardia, which has developed and received regulatory approval for the remedē system – a groundbreaking technology for the treatment of central sleep apnea. CSA is a devastating disease, particularly for patients suffering also from Congestive Heart Failure. I am excited about the opportunity to bring this unique technology to the market and the many patients that can benefit. I am also looking forward to continue building a team of passionate, dedicated people to drive that effort.